WilmerHale Counsels TransMedics in Closing of $51.2M Growth Financing to Transform Organ Transplant Therapy
TransMedics, Inc., a medical technology company dedicated to improving quality, assessing viability and increasing the utilization of donor organs for transplantation announced the closing of $51.2 million growth equity financing.
TransMedics has developed the Organ Care System (OCS™), a revolutionary first-in-class technology and multi-organ platform with the potential to improve outcomes for transplant patients and to dramatically increase the number of transplantable organs worldwide. The OCS™ is the only fully portable technology that maintains donor organs in a near-physiologic state outside of the human body and addresses the current limitations of cold storage.
Read TransMedics press release for more information.